Comparative Analysis of Disease-Modifying Therapies for Multiple Sclerosis

Ohikhuare Okun^1*, Rapahel Udedike², Ohene Poku Agyemang³, Promise Eromosele Ogbewele⁴, Omoikhoa Irele-Ifijeh⁵, Michael Iboyi⁶, Osahon Rex Igbinomwanhia⁷, Jatto Obehi Immaculate⁸

Abstract

This review examines the role of disease-modifying therapies (DMTs) in treating multiple sclerosis, a chronic autoimmune disease affecting the central nervous system. DMTs have been shown to reduce relapse rates, slow disease progression, and improve quality of life for patients with MS. The different classes of DMTs, including injectable, oral, and infusion therapies, offer varying benefits and risks. Understanding the efficacy, safety, and impact of DMTs on quality of life is essential for healthcare providers to deliver optimal care and improve patient outcomes.

Keywords

multiple sclerosis; disease-modifying therapies; relapse prevention; quality of life; treatment efficacy.

Cite This Article

Okun, O., Udedike, R., Agyemang, O. P., Ogbewele, P. E., Ifijeh-Irele, O., Iboyi, M., Igbinomwanhia, O. R., Immaculate, J. O. (2025). Comparative Analysis of Disease-Modifying Therapies for Multiple Sclerosis. International Journal of Scientific Advances (IJSCIA), Volume 6| Issue 4: Jul – Aug 2025, Pages 772-775 URL: https://www.ijscia.com/wp-content/uploads/2025/07/Volume6-Issue4-Jul-Aug-No.927-772-775.pdf

Volume 6 | Issue 4: Jul – Aug 2025